↓ Skip to main content

Cancer Drug Resistance

Overview of attention for book
Cover of 'Cancer Drug Resistance'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint
  3. Altmetric Badge
    Chapter 2 Classical and Targeted Anticancer Drugs: An Appraisal of Mechanisms of Multidrug Resistance.
  4. Altmetric Badge
    Chapter 3 In Vitro Methods for Studying the Mechanisms of Resistance to DNA-Damaging Therapeutic Drugs.
  5. Altmetric Badge
    Chapter 4 In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin.
  6. Altmetric Badge
    Chapter 5 Uptake and Permeability Studies to Delineate the Role of Efflux Transporters.
  7. Altmetric Badge
    Chapter 6 Dynamics of Expression of Drug Transporters: Methods for Appraisal.
  8. Altmetric Badge
    Chapter 7 Fluorimetric Methods for Analysis of Permeability, Drug Transport Kinetics, and Inhibition of the ABCB1 Membrane Transporter
  9. Altmetric Badge
    Chapter 8 Resistance to Targeted Therapies in Breast Cancer.
  10. Altmetric Badge
    Chapter 9 MicroRNAs and Cancer Drug Resistance
  11. Altmetric Badge
    Chapter 10 The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols for Extraction and PCR Analysis
  12. Altmetric Badge
    Chapter 11 Methods for Studying MicroRNA Expression and Their Targets in Formalin-Fixed, Paraffin-Embedded (FFPE) Breast Cancer Tissues
  13. Altmetric Badge
    Chapter 12 The Regulatory Role of Long Noncoding RNAs in Cancer Drug Resistance
  14. Altmetric Badge
    Chapter 13 Cancer Exosomes as Mediators of Drug Resistance.
  15. Altmetric Badge
    Chapter 14 Isolation and Characterization of Cancer Stem Cells from Primary Head and Neck Squamous Cell Carcinoma Tumors
  16. Altmetric Badge
    Chapter 15 Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.
  17. Altmetric Badge
    Chapter 16 Proteomics in the Assessment of the Therapeutic Response of Antineoplastic Drugs: Strategies and Practical Applications.
  18. Altmetric Badge
    Chapter 17 Managing Drug Resistance in Cancer: Role of Cancer Informatics
  19. Altmetric Badge
    Chapter 18 Erratum to: In Vitro Methods for Studying the Mechanisms of Resistance to DNA-Damaging Therapeutic Drugs
Attention for Chapter 12: The Regulatory Role of Long Noncoding RNAs in Cancer Drug Resistance
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
The Regulatory Role of Long Noncoding RNAs in Cancer Drug Resistance
Chapter number 12
Book title
Cancer Drug Resistance
Published in
Methods in molecular biology, January 2016
DOI 10.1007/978-1-4939-3347-1_12
Pubmed ID
Book ISBNs
978-1-4939-3345-7, 978-1-4939-3347-1
Authors

Askarian-Amiri, Marjan E., Leung, Euphemia, Finlay, Graeme, Baguley, Bruce C., Marjan E. Askarian-Amiri, Euphemia Leung, Graeme Finlay, Bruce C. Baguley

Editors

Jose Rueff, António Sebastião Rodrigues

Abstract

Recent genomic and transcriptomic analysis has revealed that the majority of the human genome is transcribed as nonprotein-coding RNA. These transcripts, known as long noncoding RNA, have structures similar to those of mRNA. Many of these transcripts are now thought to have regulatory roles in different biological pathways which provide cells with an additional layer of regulatory complexity in gene expression and proteome function in response to stimuli. A wide variety of cellular functions may thus depend on the fine-tuning of interactions between noncoding RNAs and other key molecules in cell signaling networks. Deregulation of many noncoding RNAs is thought to occur in a variety of human diseases, including neoplasia and cancer drug resistance. Here we discuss recent findings on the molecular functions of long noncoding RNAs in cellular pathways mediating resistance to anticancer drugs.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 14%
Researcher 3 14%
Student > Bachelor 2 10%
Student > Master 2 10%
Other 1 5%
Other 4 19%
Unknown 6 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 29%
Medicine and Dentistry 2 10%
Unspecified 1 5%
Agricultural and Biological Sciences 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Other 2 10%
Unknown 8 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 February 2016.
All research outputs
#17,789,675
of 22,852,911 outputs
Outputs from Methods in molecular biology
#7,242
of 13,127 outputs
Outputs of similar age
#267,695
of 393,602 outputs
Outputs of similar age from Methods in molecular biology
#752
of 1,470 outputs
Altmetric has tracked 22,852,911 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,127 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 393,602 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,470 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.